Join What's App Group for Pharma Jobs

Aurobindo Pharma Walk In On 14th March for Research Scientist

Aurobindo Pharma Hiring B.Pharm/ M.Pharm.”AUROBINDO PHARMA LTD” (APL). APL is a growing Indian multinational pharmaceutical manufacturing firm with turnover of over US$2.8 Billion revenues for 2018-19, with presence in more than 34 countries frontend presence with products exported to 155 nations. Interested and eligible candidates apply online with link provide at bottom and check eligibility before apply and Eligibility details as follows .

Vacancy details :

  • Company Name: Aurobindo Pharma  
  • Location : Hyderabad( Bachupally )
  • Post Name: Research Scientist
  • Qualification: B.Pharm/ M.Pharm
  • Experience :02-07 years
  • No of Vacancies :10
  • Salary: Not Disclosed
  • Time and Venue :14th March , 10 AM onwards

    Aurobindo Pharma Ltd. Research Centre-I, Sy. No. 313, Bachupally, Quthbullapur Mandal, Hyderabad, Telangana-500090.
    Contact – Sowjanya 

Job Description/skills Required:

1. Competent with Europe/ US/ Canada/ South Africa -filing requirements with respect to Modules 2 & 3. Ability to independently and effectively review technical documents related to
2. Well versed with Europe/ US/ Canada/ South Africa -Regulatory Guidance and Processes (i.e. Ability to understand and interpret technical expectations as per applicable ICH and Europe/ US/ Canada/ South Africa guidelines)
3. Sound knowledge of basic aspects of a Formulation (primarily pharmaceutical development along with general analytical aspects)
4. Should be aware of Post-approval variation requirements in Europe/ US/ Canada/ South Africa and have ability to take decisions related to the variation categorization. Should have basic QA knowledge to enable correct review of related change controls and decide on any impact on regulatory front in terms of variation.

Selection Process: Shortlisted candidates may called for selection process including personal interview and Group discussion ,Exam

Click here for full details :

Author: Niranjan Reddy

Leave a Reply